Coronary artery disease exhibits growing mortality and morbidity worldwide despite the
advances in pharmacotherapy and coronary intervention. Coronary artery disease is …

Antiplatelet therapy, the cornerstone of post coronary stenting antithrombotic therapy,
reduces the rate of hard clinical endpoints in patients treated both conservatively and …

Coronary heart disease is the leading cause of death in the Western world. Antithrombotic
therapy is the cornerstone of its successful treatment. Clinical trials have demonstrated that …

Coronary artery disease (CAD) is one of the leading causes of death in Taiwan. Despite the
use of current guideline-recommended therapies for secondary prevention, the residual risk …

Introduction: Despite the undeniable benefits on reducing ischemic adverse events,
antiplatelet regimens including dual antiplatelet therapy (DAPT) with aspirin and P2Y12 …

Antithrombotic therapy is the cornerstone of the pharmacological treatment in patients with
established coronary artery disease (CAD). 1 Despite technological improvements, the …

Coronary heart disease is the leading cause of death in the US and the industrialized world.
Ever since DeWood in 1980 demonstrated that a thrombus was the primary event leading to …

Multiple guidelines and consensus papers have addressed the role of antithrombotic
strategies in patients with established coronary artery disease (CAD). Since evidence and …

The antithrombotic treatment of coronary artery disease is becoming increasingly complex.
Aspirin is often combined with more potent antiplatelet agents such as thienopyridines and …

Introduction Antiplatelet therapy is the cornerstone for prevention and management of
ischemic complications among patients with coronary artery disease. Over the past decades …